Assembly Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Assembly Biosciences, Inc. (ASMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.95 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-04.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-03-04
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-09-30 was 131.50K shares, a 94.86% decline year-over-year.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-06-30 was 233.50K shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-03-31 was 12.50K shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-12-31 was 68.00K shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.95M shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 2.75M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2019-12-31 | 1.95M shares 10-K · filed 2020-03-04 | |||
| 2015-09-30 | 131.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 365.00K shares derived: sum of 2 quarters · filed 2015-11-09 | 377.50K shares 10-Q · filed 2015-11-09 | 445.50K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 233.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 246.00K shares 10-Q · filed 2015-08-13 | 314.00K shares derived: sum of 3 quarters · filed 2015-08-13 | 2.87M shares derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | 12.50K shares 10-Q · filed 2015-05-08 | 80.50K shares derived: sum of 2 quarters · filed 2015-05-08 | 2.64M shares derived: sum of 3 quarters · filed 2015-05-08 | |
| 2014-12-31 | 68.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 2.63M shares derived: sum of 2 quarters · filed 2015-03-16 | 2.75M shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 2.56M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | 2.68M shares 10-Q · filed 2014-11-17 | ||
| 2014-06-30 | 122.70K shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |